- Trials with a EudraCT protocol (91)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (11)
91 result(s) found for: Marketing authorisation.
Displaying page 1 of 5.
| EudraCT Number: 2007-001152-39 | Sponsor Protocol Number: SSG XX | Start Date*: 2024-05-21 |
| Sponsor Name:Scandinavian Sarcoma Group | ||
| Full Title: SSGXX A Scandinavian Sarcoma Group treatment protocol for adult patients with non-metastatic high-risk soft tissue sarcoma of the extremities and trunk wall | ||
| Medical condition: SSG XX is a phase II trial for high-risk soft tissue sarcoma(STS) of the extremities and trunk wall. Prognostic markers are used to identify high-risk tumors. SSG XX will evaluate chemo-and radioth... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NO (Completed) SE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2019-004153-93 | Sponsor Protocol Number: iEuroEwing | Start Date*: 2022-06-17 |
| Sponsor Name:German Paediatric Oncology Group | ||
| Full Title: INTERNATIONAL EURO EWING TRIAL FOR TREATMENT OPTIMISATION IN PATIENTS WITH EWING SARCOMA | ||
| Medical condition: Ewing Sarcoma | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
| Trial protocol: DE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2022-002241-18 | Sponsor Protocol Number: 983.974.742 | Start Date*: 2023-03-14 |
| Sponsor Name:Helse Bergen HF | ||
| Full Title: Diagnostic treatment-trial for autonomous cortisol secretion- a tool to select patients for adrenalectomy | ||
| Medical condition: autonomous cortisol secretion | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NO (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2006-004927-12 | Sponsor Protocol Number: 06-09-2006-0208-296-2401 | Start Date*: 2009-11-20 |
| Sponsor Name:St Helier Hospital NHS Trust | ||
| Full Title: A double-blind randomised placebo controlled study of cotrimoxazole in the treatment of advanced pulmonary fibrosis | ||
| Medical condition: Advanced pulmonary fibrosis including common subtypes of usual interstitial pneumonitis and fibrotic non specific pneumonitis | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (GB - no longer in EU/EEA) | ||
| Trial results: View results | ||
| EudraCT Number: 2008-007319-33 | Sponsor Protocol Number: OP08/8679 | Start Date*: 2009-02-19 |
| Sponsor Name:Leeds Teaching Hospitals NHS Trust | ||
| Full Title: Do genes predict response to treatment in age-related macular degeneration? | ||
| Medical condition: Choroidal neovascularisation secondary to age-related macular degeneration (ARMD) | ||
| Disease: | ||
| Population Age: Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2004-000029-31 | Sponsor Protocol Number: GIPF-007 | Start Date*: 2005-01-28 |
| Sponsor Name:InterMune | ||
| Full Title: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of the Safety and Efficacy of Interferon gamma-Ib in patients with Idiopathic Pulmonary Fibrosis The INSPIRE Trial - International Stu... | ||
| Medical condition: Idiopathic Pulmonary Fibrosis (IPF) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: IE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-002898-19 | Sponsor Protocol Number: IndiviStat#1 | Start Date*: 2018-01-08 |
| Sponsor Name:Helsinki University Central Hospital | ||
| Full Title: There is no English name for the trial. | ||
| Medical condition: Primary prevention of atherosclerotic disease | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: FI (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2021-000683-30 | Sponsor Protocol Number: CoVacc | Start Date*: 2021-03-03 |
| Sponsor Name:Umeå university | ||
| Full Title: CoVacc - Immune response to vaccination against Covid-19, an open multicenter phase IV study | ||
| Medical condition: Individuals with and without pre-existing immunity to Covid-19. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2017-005142-29 | Sponsor Protocol Number: UC-0107/1718 | Start Date*: 2018-08-30 |
| Sponsor Name:UNICANCER | ||
| Full Title: PD-(L)1 iNhibitors with concurrent IRadiation at VAried tumour sites in advanced Non-small cell lung cAncer | ||
| Medical condition: Advanced (stage IIIB/IIIC/IV) NSCLC patients eligible for treatment with a PD-1 or PD-L1 antagonist according to the European Marketing Authorisation in a first line or a second line | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: FR (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2013-004743-23 | Sponsor Protocol Number: CAPIT-001 | Start Date*: 2013-12-10 | |||||||||||
| Sponsor Name:Hull and East Yorkshire Hospital Trust | |||||||||||||
| Full Title: A randomised controlled trial to assess the clinical and cost effectiveness of pre-operative skin cleansing with chlorhexidine and povidone-iodine in preventing surgical site infection and establis... | |||||||||||||
| Medical condition: Incidence of Surgical Site infection following clean or clean-contaminated, non-implant, vascular surgery | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2004-000766-12 | Sponsor Protocol Number: SCO/BIA-2093-301 | Start Date*: 2005-03-21 |
| Sponsor Name:BIAL Portela & Companhia, S.A. | ||
| Full Title: Efficacy and safety of BIA 2-093 as adjunctive therapy for refractory partial seizures in a double-blind, randomised, placebo-controlled, parallel-group, multicentre clinical trial | ||
| Medical condition: About 40% of the patients suffering from epilepsy are not satisfactorily controlled and 25% suffer from significant adverse events. This lack of seizure control means that combination therapy is of... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2004-003814-40 | Sponsor Protocol Number: FE200486 CS12A | Start Date*: 2005-02-01 | |||||||||||
| Sponsor Name:Ferring Pharmaceuticals A/S | |||||||||||||
| Full Title: An open-label, multi-centre, extension study evaluation the long-term safety and tolerability of Degarelix one-month depots in patients with prostate cancer | |||||||||||||
| Medical condition: Prostate Cancer | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male | ||||||||||||
| Trial protocol: HU (Completed) DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2011-003168-63 | Sponsor Protocol Number: AMLSG16-10/CPKC412ADE02T | Start Date*: 2012-04-27 |
| Sponsor Name:University Hospital Ulm | ||
| Full Title: Phase-II study evaluating midostaurin in induction, consolidation and maintenance therapy also after allogeneic blood stem cell transplantation in patients with newly diagnosed acute myeloid leuk... | ||
| Medical condition: Patients with confirmed diagnosis of AML or related precursor neoplasm, or acute leukemia of ambiguous lineage (classified according to the World Health Organization (WHO) 2008 classification) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Completed) AT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2009-016566-82 | Sponsor Protocol Number: 05/SP/120 | Start Date*: 2009-12-29 |
| Sponsor Name:Belfast Health and Social Care Trust [...] | ||
| Full Title: Skin bacteria as a source of surgical infections: molecular epidemiology and prevention of wound contaimination | ||
| Medical condition: No medical condition under investigation, investigation of surgical wound contamination in spinal patients. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2020-002238-34 | Sponsor Protocol Number: FFA-MAE-EXT | Start Date*: 2021-03-22 | |||||||||||
| Sponsor Name:University Hospital Schleswig-Holstein (UKSH) | |||||||||||||
| Full Title: Open label extension study for monitoring long-term safety in patients with Myoclonic Astatic Epilepsy (Doose-Syndrome) receiving Fenfluramine as add-on therapy | |||||||||||||
| Medical condition: Childhood epilepsy: Myoclonic Astatic Epilepsy (Doose-Syndrome) | |||||||||||||
|
|||||||||||||
| Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Trial now transitioned) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2012-000068-11 | Sponsor Protocol Number: SAVDEX-12 | Start Date*: 2012-05-16 |
| Sponsor Name:Turku University Hospital | ||
| Full Title: The effects of dexmedetomidine on cerebral autoregulation and cerebral oxygenation in subarachnoid haemorrhage patients. | ||
| Medical condition: This study will be conducted on aneurysmal subarachnoid hemorrhage patients. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: FI (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2021-001817-35 | Sponsor Protocol Number: 111958 | Start Date*: 2021-08-04 |
| Sponsor Name:Radboud University Medical Center | ||
| Full Title: Suboxone (buprenorphine/naloxone) versus methadone opioid rotation in patients with escalated opioid use and chronic pain: a randomized trial. | ||
| Medical condition: Opioid use disorder | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2022-003218-36 | Sponsor Protocol Number: 82646 | Start Date*: 2023-06-05 |
| Sponsor Name:Radboudumc | ||
| Full Title: The safety of ticagrelor monotherapy after primary percutaneous coronary intervention for ST-elevation myocardial infarction and the effect on intramyocardial haemorrhage | ||
| Medical condition: Acute myocardial infarction | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2007-005547-17 | Sponsor Protocol Number: RHMNUT0048 | Start Date*: 2010-01-28 |
| Sponsor Name:Southampton University Hospital NHS Trust | ||
| Full Title: Refeeding risks in patients requiring nutrition support. A twin centre double-blind randomised controlled trial of parenteral nutrition support. | ||
| Medical condition: Patients who have a non-functioning gastrointestinal tract require artifical intravenous nutrition. This is usally a result recent surgery or sepsis causing a reversible short term paralysis of th... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (GB - no longer in EU/EEA) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2021-002634-16 | Sponsor Protocol Number: NL76533.041.21 | Start Date*: 2021-08-25 |
| Sponsor Name:University Medical Center Utrecht | ||
| Full Title: Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiation in sarcopenic patients with head and neck squamous cell carcinoma | ||
| Medical condition: The IMP will be used to treat locally advanced head and neck squamous cell carcinoma (HNSCC). Patients with low skeletal muscle mass will be randomized between two schedules: 1) weekly 40 mg/m2 cis... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Trial now transitioned) | ||
| Trial results: (No results available) | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
